Antibody generation technology
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
3,305
NCT01149837
Evaluation of InnoLIA HTLV I/II Score
Phase: N/A
Role: Lead Sponsor
Start: Jul 31, 2013
Completion: Jan 25, 2019
Loading map...